FDA: Blood Substitute Test Shouldn’t Go On

WASHINGTON - A Navy plan to test a blood substitute on civilian trauma victims should remain on hold, federal health advisers recommended Thursday, saying the experiment’s risks outweigh its benefits. >>> Discuss This Story

MORE ON THIS TOPIC